Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. ClearPoint Neuro Inc shares valued at $14,787,374 were purchased by PTC Therapeutics, Inc. on Nov 12 ’25. At $16.53 per share, PTC Therapeutics, Inc. acquired 894,578 shares.
Also, BURNETT JOSEPH sold 26,463 shares, netting a total of over 714,021 in proceeds. Following the sale of shares at $26.98 each, the insider now holds 217,059 shares.
Before that, JOSEPH M BURNETT TRUST had added 26,463 shares to its account. In a trade valued at $766,368, the Affiliate of Director bought ClearPoint Neuro Inc shares for $28.96 each.
Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in late October.
Analyzing CLPT Stock Performance
On last trading session, ClearPoint Neuro Inc [NASDAQ: CLPT] plunged -3.97% to $16.71. The stock’s lowest price that day was $16.2901, but it reached a high of $17.65 in the same session. During the last five days, there has been a drop of approximately -1.59%. Over the course of the year, ClearPoint Neuro Inc shares have jumped approximately 43.43%. Shares of the company reached a 52-week high of $30.10 on 10/09/25 and a 52-week low of $9.76 on 04/07/25.
Support And Resistance Levels for ClearPoint Neuro Inc (CLPT)
According to the 24-hour chart, there is a support level at 16.12, which, if violated, would cause prices to drop to 15.52. In the upper region, resistance lies at 17.48. The next price resistance is at 18.24. RSI (Relative Strength Index) is 38.11 on the 14-day chart, showing neutral technical sentiment.
Is ClearPoint Neuro Inc subject to short interest?
Stocks of ClearPoint Neuro Inc saw a sharp steep in short interest on 2025-10-31 dropping by 67024.0 shares to 2.5 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 2.57 million shares. A decline of -2.68% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.67 of the overall float, the days-to-cover ratio (short ratio) decline to 2.67.
Which companies own the most shares of ClearPoint Neuro Inc (CLPT)?
In terms of ClearPoint Neuro Inc share price expectations, FactSet research, analysts set an average price target of 15 in the next 12 months, down nearly -13.79% from the previous closing price of $17.4. Analysts anticipate ClearPoint Neuro Inc stock to reach 30 by 2025, with the lowest price target being 9. On March 18, 2021, Lake Street assigned a price target of “a Buy” to the stock and initiated coverage with a $32.
